This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Kyushu University, Lsi Medience Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 455 
1 out of 27 Years Active: 2026
Title: Dongchon Kang and His Work in Bladder Cancer Diagnosis.
Introduction
Dongchon Kang is an inventor based in Fukuoka, Japan. His patent work focuses on a method intended to support the early and accurate diagnosis of bladder cancer.
Latest Patents
Kang is associated with 1 patent, titled “Diagnosis Method for Bladder Cancer.” The invention identifies substances in urinary microvesicles from patients with bladder cancer. It describes enriching the microvesicles and assessing the amount of a marker protein they contain to help determine whether a patient has bladder cancer.
Career Highlights
Kang’s listed professional affiliations include LSI Medience Corporation and Kyushu University. His work connects medical research with diagnostic applications.
Collaborations
Kang’s listed coworker is Takeshi Uchiumi. The available information identifies their association but does not specify the details of their collaboration.
Conclusion
Dongchon Kang’s patent centers on using urinary microvesicles and marker proteins to assist in bladder cancer diagnosis, reflecting his work across medical research and diagnostic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile